Transdermal application of steroid hormones for contraception
- 1 June 1995
- journal article
- review article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 53 (1-6) , 247-251
- https://doi.org/10.1016/0960-0760(95)00055-5
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Suppression of ovarian function with the transdermally given synthetic progestin ST 1435Fertility and Sterility, 1992
- Transdermal absorption of the progestin ST-1435: Therapeutic serum steroid concentrations and high excretion of the steroid in salivaContraception, 1991
- Suppression of ovulation by transdermal oestradiol patches.BMJ, 1988
- Pharmacokinetics and pharmacodynamics of transdermal dosage forms of 17β-estradiol: Comparison with conventional oral estrogens used for hormone replacementAmerican Journal of Obstetrics and Gynecology, 1985
- Pharmacokinetic and pharmacodynamic investigations with vaginal devices releasing levonorgestrel at a constant, near zero order rateContraception, 1982
- Clinical performance and endocrine profiles with contraceptive vaginal rings containing a combination of estradiol andd-norgestrelAmerican Journal of Obstetrics and Gynecology, 1978
- Potencies of oral contraceptivesAmerican Journal of Obstetrics and Gynecology, 1976
- In VivoStudies on Progesterone Metabolism by Human SkinJournal of Clinical Endocrinology & Metabolism, 1969
- Percutaneous Absorption of SteroidsJournal of Investigative Dermatology, 1969
- Percutaneous Penetration of Steroids in Man*Journal of Investigative Dermatology, 1969